Nektar Therapeutics (MM)
   
To register click here

Nektar Therapeutics Stock Price NKTR

Company Description : A biopharmaceutical company that develops and enables differentiated therapeutics with its PEGylation and pulmonary drug development technology platforms. url: www.nektar.com

Name:
Nektar Therapeutics (MM)
Symbol:
NASDAQ:NKTR
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.133.234.153.755.254.243.394.0120:00:02
To register Click hereRegister for free Nektar Therapeutics stock prices.

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) : Phase 2 Study for NKTR-102 Will Target Newly-Identified K-Ras Mutated Oncogene Population in Patients with Advanced Colorectal Cancer SAN CARLOS, Calif., June 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics (NASDAQ:NKTR...

Free Nektar Therapeutics Stock Charts

Nektar Therapeutics Historical Stock Chart
Nektar Therapeutics Historical Stock Chart
Nektar Therapeutics Monthly Stock Chart
Nektar Therapeutics Monthly Stock Chart
Nektar Therapeutics Intraday stock chart
Nektar Therapeutics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Nektar Therapeutics stock Price, quotes, trades and FREE Nektar Therapeutics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Nektar Therapeutics (NKTR) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Nektar Therapeutics News

Latest Nektar Therapeutics News Headlines
DateTimeSource
Headline
06/02/20088:31AMPRNUSNektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
06/02/20088:30AMPRNUSNew Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Molecule PEG-Oncolyti
06/02/20089:12AMTFNFNektar Therapeutics announces positive data from NKTR-102 Phase I study
05/30/20088:30AMPRNUSNektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotec
05/22/20088:00AMPRNUSBharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
05/19/20081:30PMPRNUSAmikacin Inhale Shows Promising Results in Phase II Study
05/16/20089:01AMTFNFNektar product shows 'significant anti-tumor activity' in Phase I trial
05/16/20088:30AMPRNUSSignificant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Procee
05/12/20089:00AMPRNUSNektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
05/07/20084:25PMPRNUSNektar Therapeutics Announces First Quarter 2008 Results
05/07/20084:10PMPRNUSNektar Receives Patent Covering Pulmonary Targeted Antibiotics
05/07/20089:00AMPRNUSNKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Socie

Nektar Therapeutics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Nektar Therapeutics company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Nektar Therapeutics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  125275 4.1001 07/18/2008 4:19PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
36 site:2us nasdaq nktr080720 07:17 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )